Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Molecular determinants of Grb14-mediated inhibition of insulin signaling.
Goenaga D
,
Hampe C
,
Carré N
,
Cailliau K
,
Browaeys-Poly E
,
Perdereau D
,
Holt LJ
,
Daly RJ
,
Girard J
,
Broutin I
,
Issad T
,
Burnol AF
.
???displayArticle.abstract??? Grb14 belongs to the Grb7 family of molecular adapters and was identified as an inhibitor of insulin signaling. Grb14 binds to activated insulin receptors (IR) and inhibits their catalytic activity. To gain more insight into the Grb14 molecular mechanism of action, we generated various mutants and studied the Grb14-IR interaction using coimmunoprecipitation and bioluminescence resonance energy transfer (BRET) experiments. Biological activity was further analyzed using the Xenopus oocyte model and a functional complementation assay measuring cellular proliferation rate in Grb14 knockout mouse embryonic fibroblasts. These studies identified two important interaction sites, Grb14 L404-IR L1038 and Grb14 R385-IR K1168, involving the IR alphaC-helix and activation loop, respectively. Interestingly, the former involves residues that are likely to be crucial for the specificity of IR binding with regard to other members of the Grb7 family. In addition, mutation of the Grb14-S370 residue suggested that its phosphorylation status controlled the biological activity of the protein. We further demonstrated that insulin-induced Grb14-PDK1 interaction is required in addition to Grb14-IR binding to mediate maximal inhibition of insulin signaling. This study provides important insights into the molecular determinants of Grb14 action by demonstrating that Grb14 regulates insulin action at two levels, through IR binding and by interfering with downstream pathways. Indeed, a precise knowledge of the molecular mechanism of insulin signaling inhibition by Grb14 is a prerequisite for the development of insulin-sensitizing molecules to treat pathophysiological states such as obesity or type 2 diabetes.
Angers,
Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).
2000, Pubmed
Angers,
Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).
2000,
Pubmed
Asante-Appiah,
Protein tyrosine phosphatases: the quest for negative regulators of insulin action.
2003,
Pubmed
Boussif,
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
1995,
Pubmed
Boute,
Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer.
2001,
Pubmed
Béréziat,
Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14.
2002,
Pubmed
Cailliau,
Inhibition of FGF receptor signalling in Xenopus oocytes: differential effect of Grb7, Grb10 and Grb14.
2003,
Pubmed
,
Xenbase
Cailliau,
FGF receptor phosphotyrosine 766 is a target for Grb14 to inhibit MDA-MB-231 human breast cancer cell signaling.
2005,
Pubmed
,
Xenbase
Cariou,
The adapter protein ZIP binds Grb14 and regulates its inhibitory action on insulin signaling by recruiting protein kinase Czeta.
2002,
Pubmed
,
Xenbase
Cariou,
Increased adipose tissue expression of Grb14 in several models of insulin resistance.
2004,
Pubmed
Carré,
Dual effect of the adapter growth factor receptor-bound protein 14 (grb14) on insulin action in primary hepatocytes.
2008,
Pubmed
Cooney,
Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice.
2004,
Pubmed
Depetris,
Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14.
2005,
Pubmed
Desbuquois,
Compartmentalization and in vivo insulin-induced translocation of the insulin-signaling inhibitor Grb14 in rat liver.
2008,
Pubmed
El-Etr,
Meiotic maturation in Xenopus laevis oocytes initiated by insulin.
1979,
Pubmed
,
Xenbase
Ellis,
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.
1986,
Pubmed
Ferrell,
The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Gual,
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
2005,
Pubmed
Holt,
Grb10 and Grb14: enigmatic regulators of insulin action--and more?
2005,
Pubmed
Howard,
Attenuation of leptin and insulin signaling by SOCS proteins.
2006,
Pubmed
Hubbard,
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.
1997,
Pubmed
Kairouz,
Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells.
2005,
Pubmed
Kasus-Jacobi,
Identification of the rat adapter Grb14 as an inhibitor of insulin actions.
1998,
Pubmed
Kasus-Jacobi,
Evidence for a direct interaction between insulin receptor substrate-1 and Shc.
1997,
Pubmed
King,
The adaptor protein Grb14 regulates the localization of 3-phosphoinositide-dependent kinase-1.
2004,
Pubmed
Moncoq,
The PIR domain of Grb14 is an intrinsically unstructured protein: implication in insulin signaling.
2003,
Pubmed
,
Xenbase
Nouaille,
Interaction with Grb14 results in site-specific regulation of tyrosine phosphorylation of the insulin receptor.
2006,
Pubmed
Shen,
Grb7 in intracellular signaling and its role in cell regulation.
2004,
Pubmed
Sleeman,
Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.
2005,
Pubmed
Virkamäki,
Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.
1999,
Pubmed
